Feature image

What's New

Provisional approval of COVID-19 Vaccine Janssen

Medsafe has provisionally approved COVID-19 Vaccine Janssen under section 23 of the Medicines Act 1981, with conditions.

Find out more

News and Events

Date Type Title
21/07/2021Alert CommunicationMyocarditis and pericarditis - rare adverse reactions to Comirnaty (Pfizer COVID-19 vaccine)
21/07/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #18 – 3 July 2021
19/07/2021CommitteesMinutes of the 186th meeting of the Medicines Adverse Reaction Committee - 10 June 2021
14/07/2021CommitteesAgenda for the 112th meeting of the Medicines Assessment Advisory Committee - 15 July 2021
14/07/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #17 – 26 June 2021
7/07/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #16 – 19 June 2021
7/07/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #15 – 12 June 2021
30/06/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #14 – 5 June 2021
30/06/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #13 – 29 May 2021
23/06/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #12 – 22 May 2021
16/06/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #11 – 15 May 2021
14/06/2021CommitteesAgenda for the 111th meeting of the Medicines Assessment Advisory Committee - 15 June 2021
9/06/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #10 – 8 May 2021
9/06/2021Monitoring CommunicationM² Logo Myocarditis – a potential adverse reaction to Comirnaty (Pfizer COVID-19 vaccine)
3/06/2021PublicationsPrescriber Update - Vol. 42 No. 2 June 2021
2/06/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #9 – 1 May 2021
31/05/2021Monitoring CommunicationM² Logo Pregabalin and the possible risk of bullous dermatitis and exfoliating skin reactions - Monitoring closes 25 November 2021
28/05/2021COVID-19Comirnaty (Pfizer COVID-19 vaccine) storage conditions updated
27/05/2021CommitteesAgenda for the 186th Medicines Adverse Reactions Committee meeting - 10 June 2021
26/05/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #8 – 24 April 2021